We are honored to announce WuXi AppTec has been awarded the 2017 Frost & Sullivan Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award.

The award is part of the Frost & Sullivan Best Practices Award series, which recognizes best-in-class companies that have demonstrated excellence in their respective industries. WuXi has been recognized for its strong growth performance, alignment with market needs, breadth of products and solutions, and strategy and achievements

We thank Frost & Sullivan for recognizing WuXi’s role in helping our partners develop innovative products through our open-access capability and technology platform. We will continue to strengthen our platform to enable our collaborative partners, and to fulfill WuXi’s dream that every drug can be made and every disease can be treated.

Related Link:

http://www.wuxiapptec.com/press/detail/351/18.html